NCT07215975View on ClinicalTrials.gov

A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 25, 2025

Primary Completion Date

February 28, 2030

Study Completion Date

April 17, 2031

Conditions
β-thalassemia
Interventions
DRUG

Luspatercept

According to the product label

Trial Locations (1)

Unknown

Prince Muhammad bin Nasser Hospital, Jizan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT07215975 - A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East | Biotech Hunter | Biotech Hunter